SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-211294
Filing Date
2013-05-09
Accepted
2013-05-09 16:50:44
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d512332d10q.htm 10-Q 565389
2 EX-31.1 d512332dex311.htm EX-31.1 10795
3 EX-31.2 d512332dex312.htm EX-31.2 10835
4 EX-32.1 d512332dex321.htm EX-32.1 5355
5 EX-32.2 d512332dex322.htm EX-32.2 5375
  Complete submission text file 0001193125-13-211294.txt   4194491

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dvax-20130331.xml EX-101.INS 593557
7 XBRL TAXONOMY EXTENSION SCHEMA dvax-20130331.xsd EX-101.SCH 37456
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20130331_cal.xml EX-101.CAL 53322
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20130331_def.xml EX-101.DEF 241330
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20130331_lab.xml EX-101.LAB 348380
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20130331_pre.xml EX-101.PRE 278604
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 13829624
SIC: 2834 Pharmaceutical Preparations